Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 344 entries
View as:

Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06474481 Org: User:
Start: 07/31/24 End: 12/31/29 Due: 12/31/30

Methods of Computed Tomography Screening and Management of Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03992833 Org: User:
Start: 05/01/17 End: 09/30/22 Due: 09/30/23

Preoperative Biliary Drainage for the Lower Malignant Obstructive Jaundice

Phase: N/A Priority: Normal
NCT ID: NCT01744938 Org: User:
Start: 09/30/12 End: 12/31/16 Due: 12/31/17

A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02272894 Org: User:
Start: 07/31/14 End: 12/31/16 Due: 12/31/17

Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00973310 Org: User:
Start: 10/31/09 End: 12/31/16 Due: 12/31/17

SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT04836520 Org: User:
Start: 08/02/21 End: 03/31/23 Due: 03/31/24

Drug-eluting Beads Bronchial Arterial Chemoembolization in Stage II-III Non-small-cell Lung Cancer Patients Failed, Refused or Ineligible to Receive Standard Treatments

Phase: N/A Priority: Normal
NCT ID: NCT04825925 Org: User:
Start: 05/01/21 End: 10/01/24 Due: 10/01/25

Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05627427 Org: User:
Start: 07/01/22 End: 12/31/24 Due: 12/31/25

A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT07019233 Org: User:
Start: 09/01/24 End: 12/31/26 Due: 12/31/27

GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05215665 Org: User:
Start: 01/15/22 End: 01/15/26 Due: 01/15/27

Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT01683175 Org: User:
Start: 08/31/12 End: 10/31/20 Due: 10/31/21

Metformin Plus Sorafenib for Advanced HCC

Phase: N/A Priority: Normal
NCT ID: NCT02672488 Org: User:
Start: 12/31/15 End: 12/31/18 Due: 12/31/19

Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)

Phase: N/A Priority: Normal
NCT ID: NCT04807673 Org: User:
Start: 12/01/21 End: 05/31/28 Due: 05/31/29

A Clinical Study of CHT101 in CD70-Positive Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06730659 Org: User:
Start: 04/19/24 End: 04/18/39 Due: 04/18/40

Supermicrosurgical Lymphaticovenous Anastomosis for Prevention of Upper Limb Lymphedema

Phase: N/A Priority: Normal
NCT ID: NCT07026292 Org: User:
Start: 07/01/25 End: 05/31/29 Due: 05/31/30

Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research

Phase: N/A Priority: Normal
NCT ID: NCT05885776 Org: User:
Start: 09/13/22 End: 09/30/25 Due: 09/30/26

Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05908747 Org: User:
Start: 05/31/23 End: 05/31/26 Due: 05/31/27

Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02948855 Org: User:
Start: 10/31/16 End: 05/31/18 Due: 05/31/19

Bicyclol in the Treatment of Antineoplastic Drug-induced Liver Injury.

Phase: N/A Priority: Normal
NCT ID: NCT05711459 Org: User:
Start: 05/01/22 End: 05/01/24 Due: 05/01/25

A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06944106 Org: User:
Start: 03/28/25 End: 03/28/27 Due: 03/28/28

A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04696432 Org: User:
Start: 11/27/20 End: 12/30/23 Due: 12/30/24

Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06993025 Org: User:
Start: 05/25/25 End: 04/25/27 Due: 04/25/28

Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06141226 Org: User:
Start: 04/12/23 End: 12/30/28 Due: 12/30/29

SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites

Phase: N/A Priority: Normal
NCT ID: NCT06991478 Org: User:
Start: 05/30/25 End: 07/30/26 Due: 07/30/27

Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC

Phase: N/A Priority: Normal
NCT ID: NCT03366883 Org: User:
Start: 02/01/18 End: 12/31/22 Due: 12/31/23